EOSESOURCE.COM · DAILY NOTE ARCHIVE

EOSE Daily Investor Note — Archive

The last 30 editions of the twice-daily note from the EOSE investor dashboard, newest first. Auto-refreshed pre-open and post-close on US trading days. 🔖 Subscribe via RSS. Independent research — not investment advice; verify against primary SEC sources linked on the dashboard.

2026-09-15 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE dips 3.3% to $3.82 on quiet Sep 15 tape; Roth lifts PT to $4.50

EOSE closed $3.82 Tue Sep 15, down 3.3% vs Monday's $3.95 close on below-average volume (21.0M vs 26.5M avg). No new SEC filings or press releases today; tape quietly digests the DOE $87M advance (Sep 14) while Roth Capital's Sep 10 PT lift to $4.50 (Neutral) is the freshest sell-side signal.

$3.82 -3.29% · close Sep 15 · range $3.75–$3.97 · vol 21.0M · Yahoo Finance

Price action (Tue Sep 15): Close $3.82 (range $3.75–$3.97), vol 21.0M vs 26.5M avg (−19%). Settled lower from Mon's $3.95 close; overnight Blue Ocean ATS $3.83 (+0.26%). Orderly tape, no catalyst-driven move.
No new filings today: EDGAR shows no Form 4 or 8-K dated Sep 15. Most recent filing remains the DOE $87M FFB advance (8-K Sep 10; PR Sep 14), bringing total DOE drawings to ~$178M of the $277.5M facility.
Roth Capital (Sep 10): Maintains Neutral; raised PT $4.00→$4.50 citing DOE drawdown progress and Thorn Hill Line 2 ramp. Consensus avg PT $6.72, range $4.00–$11.00 across 11 analysts — wide spread signals high uncertainty around execution.
NYSERDA watch: Bulk storage procurement decision est. ~Sep 30 — next binary catalyst within ~2 weeks. An award could validate Z3 for US grid-scale markets; no decision yet.
Q3 setup: Earnings est. Nov 04, 2026. Market watching Thorn Hill Line 2 delivery rates and backlog additions vs the $300–$350M FY2026 guide. S-3ASR 56.5M-share shelf (Aug 31) remains active dilution overhang.

2026-09-03 22:20:00 (Stockholm) · Post-close run · US session wrap

EOSE -0.6% to $3.61 on Sep 3 — consolidating Google–MN8 bounce on light volume

EOSE slipped -0.55% to $3.61 on Thu Sep 3 2026, digesting the prior session’s 12.8% Google–MN8 WV deal surge on well-below-average volume (~14.7M vs ~22M avg). No new filings on the day; the Aug 31 S-3ASR registering 56.5M shares for resale remains the key near-term overhang.

$3.61 -0.55% · close · Thu Sep 3 2026 · Yahoo Finance / Robinhood

Price (Thu Sep 3 2026 close): $3.61 (-0.55%) from $3.63; day range $3.21–$3.69; volume ~14.7M vs ~22M avg — classic post-catalyst consolidation, no intraday follow-through on the Google–MN8 WV deal.
S-3ASR overhang (Aug 31): 56.5M shares registered for resale — 39.1M from Frontier warrants/exchange rights, 16.2M from Series B preferred conversion, 1.2M from purchase-agreement warrant. Eos receives no proceeds from resales.
CCO change (8-K Aug 24): Michelle Buczkowski appointed Chief Commercial Officer, succeeding Nathan Kroeker who exits Oct 20. Sales, BD, gov’t affairs, and marketing now report to Buczkowski; she secured the $24M Pennsylvania manufacturing grant.
Q2 2026 backdrop: $68.8M revenue (+351% YoY); FY26 guide tightened to $300–$350M; gross margin -71% (+132 pp YoY). Z3 Indensity ramp ongoing at Turtle Creek, PA. Next report ~Nov 4, 2026 (est.).
Setup Fri Sep 4: No discrete binary catalyst on deck. Watch for sell-side PT lifts post-Google/WV deal. Catalyst calendar: Ofgem BESS awards ~Sep 22, NYSERDA ~Sep 30, Q3 earnings ~Nov 4 (est.).

2026-09-01 22:22:00 (Stockholm) · Post-close run · US session wrap

EOSE -1.2% to $3.22 on Sep 1 — S-3ASR shelf live, no new filings

EOSE confirmed $3.22 close on Tue Sep 1 2026 (−1.23%), extending the post-shelf slide on below-average volume; the Aug 31 S-3ASR registering 56.5M shares for resale (Frontier JV warrants + Series B preferred) remains the dominant overhang. No new 8-K or Form 4 detected. Sep 22 Ofgem and Sep 30 NYSERDA awards are the next binary catalysts.

$3.22 -1.23% · close · Tue Sep 1 2026 · Yahoo Finance

Price (Tue Sep 1 2026 close): $3.22 (−1.23%); prior close $3.26 (Fri Aug 28, −4.68%). Light vol — Labor Day week. 52-wk range $3.11–$19.86. AH quiet. Source: Yahoo Finance.
S-3ASR (filed Aug 31) now live: Registers 39.1M Frontier Warrant/Exchange-Right shares (Cerberus/Hudson Bay JV) + 16.2M Series B preferred-conversion + 1.2M purchase-warrant shares. Eos receives no proceeds from any resale; warrant holders may sell immediately.
Frontier JV dilution math: Warrants issued Aug 4 at FPUSA JV close; 30-day registration obligation triggered the shelf. Full exercise/resale: Cerberus 35.0%→ 27.4%; Hudson Bay 9.2%→ 4.1%.
EDGAR/IR (Sep 1): No new 8-K, Form 4, or press release detected. Thorn Hill lender-approval 8-K still outstanding; CCO Kroeker departure (Aug 25) leaves commercial leadership gap.
Setup Wed Sep 2: Ofgem final BESS awards ~Sep 22, NYSERDA BESS round ~Sep 30, Q3 earnings ~Nov 4 (est.). Consensus PT $6.67 (11 analysts); B. Riley Neutral $5 (Aug 14). Q2 26: $68.8M rev (+351% YoY), FY guide $300–$350M.

2026-09-01 22:30:00 (Stockholm) · Post-close run · US session wrap

S-3ASR files 56.5M-share resale shelf — Frontier JV warrant overhang now live

The Aug 31 S-3ASR registers 56.5M shares for resale (Cerberus/Hudson Bay Frontier JV warrants + Series B preferred), cementing a structural dilution overhang one session after Thorn Hill’s surge faded on Fri’s −4.7% to $3.26. Sep 22 Ofgem and Sep 30 NYSERDA are next binary catalysts.

$3.26 -4.68% · close · Fri Aug 28 2026 · Yahoo Finance (Sep 1 real-time data not confirmed via static feed)

Price (Fri Aug 28 close): $3.26 (−4.68%); prev close $3.42. Vol 15.8M vs 25.5M avg (62%). AH Fri ~$3.27 (+0.31%). Sep 1 real-time close not confirmed via static feed; last confirmed price $3.26. 52-wk range $3.11–$19.86.
S-3ASR (filed Aug 31, post-close): Registers 39.1M Frontier Warrant/Exchange-Right shares (Cerberus/Hudson Bay JV) + 16.2M Series B preferred-conversion shares + 1.2M purchase-warrant shares. Eos receives no proceeds from any resale.
Frontier JV context: Warrants issued Aug 4 at FPUSA JV close; 30-day registration obligation triggered the shelf. If all shares sold: Cerberus stake 35.0%→ 27.4%; Hudson Bay 9.2%→ 4.1%.
EDGAR/IR today (Sep 1): No lender-approval 8-K for Thorn Hill consolidation filed as of post-close. No new Form 4 or press release detected. S-3ASR remains the dominant headline.
Setup Wed Sep 2: Ofgem final awards ~Sep 22, NYSERDA BESS ~Sep 30, Q3 earnings ~Nov 4 (est.). Consensus PT $6.67; B. Riley Neutral $5 (Aug 14, lowered from $8). Thorn Hill lender approval still outstanding.

2026-08-27 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE +22% to ~$4.08 Thu Aug 27 — Thorn Hill consolidation confirmed

Eos surged ~22% after formally announcing the consolidation of all battery manufacturing at Thorn Hill (Warrendale, PA) — a move telegraphed on the Aug 5 Q2 call and contained within FY2026 guidance of $300–$350 M. Expected 10–15% conversion-cost reduction by 2027.

$4.08 +22.20% · approx close · Thu Aug 27 2026 · derived from news-reported % move (Yahoo Finance / Simply Wall St)

Price (Thu Aug 27): Approx. close ~$4.08 (+21.7–22.8%, from $3.34 prev close); volume elevated on Thorn Hill PR. AH ~$4.97 (public.com). 52-wk range $3.11–$19.86. Avg vol ~22 M.
Thorn Hill consolidation (PR, 09:21 ET): All Z3™ battery mfg relocating from Turtle Creek Bldg 700 to the 432,000 sq ft Thorn Hill facility (Warrendale, PA); Cube assembly/testing stays at Turtle Creek Bldg 200. Target: 10–15% conversion-cost cut; ~4 GWh nameplate capacity once both lines run.
Employees & timeline: ~250 impacted employees (incl. ~205 USW union workers) each offered a role at Thorn Hill, Bldg 200, or corp HQ. Move starts Q4'26, wraps early 2027, subject to lender approvals. Customer delivery commitments held unchanged.
Within guidance — no surprise: Consolidation was outlined on the Aug 5 Q2 earnings call. FY2026 guidance remains $300–$350 M; Q2 actuals $68.8 M (+351% YoY); backlog record $807 M. No new 8-K filed today on EDGAR; announcement via press release only.
Setup Fri Aug 28: Watch EDGAR for lender-approval 8-K on the consolidation. Catalysts: Ofgem Window 1 final awards (~Sep 22 est.); NYSERDA BESS (~Sep 30 est.); Q3 earnings ~Nov est. Analyst PTs: Needham Buy/$11, Stifel Buy/$9, Truist Buy/$7 vs ~$4.08 close. Support $3.74; resistance $4.40.

2026-08-27 12:36:00 (Stockholm) · Post-close run · US session wrap

EOSE -5.6% to $3.34 Wed Aug 26 — CCO rally fades, insider Form 4 filed

Eos gave back its post-CCO announcement gains, dropping 5.6% on no fresh catalysts while the S&P gained 0.4%. A Form 4 insider filing hit EDGAR on Aug 26. Pre-market Thu recovers 2.1% to $3.41 on BofA stake build.

$3.34 -5.65% · close · Wed Aug 26 2026 · Google Finance

Price (Wed Aug 26): Closed $3.34 (−5.65%, −$0.20); range $3.31–$3.59; prev close $3.54 (Tue Aug 25). Avg vol ~27.4M. Pre-mkt Thu Aug 27: $3.41 (+2.10%). 52-wk $3.11–$19.86.
No company catalysts: No new 8-K or press release from Eos on Aug 26. Pullback appears profit-taking after the Aug 25 CCO transition announcement; broad market (S&P +0.43%, Nasdaq +0.43%) moved higher while EOSE diverged lower.
Form 4 filed (Aug 26): An insider share trade was reported with the SEC on Aug 26 (Stock Titan). Specific insider and transaction size unconfirmed; Kroeker separation agreement amendment (flagged in Aug 24 8-K) may still be forthcoming on EDGAR.
BofA raises stake (pre-mkt Aug 27): Bank of America Corp DE increased its EOSE position per regulatory disclosure, signaling continued institutional accumulation ahead of near-term catalysts.
Analyst consensus (unchanged): Stifel Buy/$9, Truist Buy/$7, Needham Buy/$11; JPM Hold/$5, TD Cowen Hold/$4, Roth Hold/$4, B. Riley Neutral/$5 (Aug 14). Street avg PT $6.67 vs $3.34 (+100% implied upside).
Setup Thu Aug 27: Pre-market +2.1% to $3.41. Watch EDGAR for Kroeker separation amendment and Form 4 detail. Catalysts: Ofgem Window 1 final awards (~Sep 22 est.); NYSERDA BESS (~Sep 30 est.); Q3 earnings ~Nov 4 est. Resistance $3.54; support $3.31.

2026-08-25 23:46:00 (Stockholm) · Post-close run · US session wrap

EOSE +2.3% to $3.54 Tue Aug 25 — CCO shakeup announced, below-avg volume

Eos edged up $0.08 (+2.31%) as the market calmly absorbed the CCO leadership change: Buczkowski (CAO) steps in, Kroeker departs Oct 20. Volume 22.9M (0.84× avg) — no panic; after-hours flat. Key news day, muted price reaction.

$3.54 +2.31% · close · Tue Aug 25 2026 · Google Finance

Price (Tue Aug 25): Closed $3.54 (+2.31%, +$0.08); range $3.44–$3.63; prev close $3.46 (Mon Aug 24). Vol 22.9M vs 27.2M avg (0.84×). A/H $3.54 (0.00%). 52-wk $3.11–$19.86.
CCO transition (8-K Aug 24, PR Aug 25): Buczkowski (CAO since Nov 25) named CCO eff. Aug 24; secured $24M PA manufacturing grant and led Golden Dome engagement. Kroeker departs Oct 20 after orderly handoff.
Kroeker legacy: Joined Jan 2023 as CFO, became CCO in 2025. Led $2B+ in capital commitments (Cerberus DDTL, DOE Loan Guarantee). Separation agreement terms not yet finalized; amendment to 8-K expected.
Analyst context: Aug 6 sweep — Stifel Buy/$9, Truist Buy/$7, Needham Buy/$11; J.P. Morgan Hold/$5, TD Cowen Hold/$4, Roth Hold/$4, B. Riley Neutral/$5 (Aug 14). Street avg PT $6.67 vs $3.54 (+88% implied upside).
Bull/Bear: Bull — $305M cash, $807M backlog, FPUSA $375M funded, Golden Dome/CAPAC pipeline. Bear — $276M Q2 net loss, FY26 guide $300–$350M (trimmed), 364M+ diluted shares, CCO transition risk, class-action scrutiny.
Setup Wed Aug 26: No scheduled catalysts. Watch EDGAR for Form 4s and Kroeker separation agreement amendment; Ofgem Window 1 final awards (~Sep 22 est.); NYSERDA BESS (~Sep 30 est.); Q3 earnings ~Nov 4 est. Resistance $3.63; support $3.44.

2026-08-21 22:20:00 (Stockholm) · Post-close run · US session wrap

EOSE drops 7.5% to $3.46 on elevated volume — stock trading below all analyst price targets

Eos fell $0.28 (-7.5%) on Friday, closing at $3.46 on volume of 36.2M shares (1.4× the 25.5M avg). Broad market sold off (S&P 500 -0.87%, Nasdaq -1.0%) but EOSE underperformed sharply. No new filings or IR releases. Stock is now below every published sell-side PT.

$3.46 -7.49% · close · Fri Aug 21 2026 · Yahoo Finance delayed

Price (Fri Aug 21): Closed $3.46 (-7.49%), range $3.28–$3.67; prev close $3.74 (Aug 20). Vol 36.2M vs 25.5M avg (1.4×). A/H: $3.45 (-0.3%). 52-wk low: $3.11.
Macro context: Risk-off session across equities — S&P 500 -0.87%, Nasdaq -1.0%, VIX +7.5% to 16.01. EOSE underperformed meaningfully; elevated volume suggests forced selling or momentum continuation.
No new catalysts today: No EDGAR filings (8-K, Form 4) or IR press releases posted Aug 21. Slide appears purely technical — post-Q2 derating extends into a second week.
Analyst PT wall: B. Riley cut PT $8→$5 (Neutral, Aug 14); TD Cowen $4 (Hold); Roth Capital $4 (Neutral). Consensus 1-yr target ~$6.67. EOSE now trades below the lowest PT on the Street.
Bull/Bear: Bull — $305M cash, $807M record backlog, FPUSA $263M funded Aug 4, Golden Dome & CAPAC defense contracts intact. Bear — stock at multi-week low, class-action scrutiny, $276M Q2 net loss, 364M+ diluted shares.
Setup Mon Aug 24: No scheduled catalysts. Watch EDGAR for Form 4 insiders; Ofgem Window 1 final awards (~Sep 22 est.); NYSERDA BESS (~Sep 30 est.); Q3 earnings ~Nov 4 est. Key support $3.28 (today’s low); floor $3.11 (52-wk low).

2026-08-20 22:20:00 (Stockholm) · Post-close run · US session wrap

EOSE slides 8.7% to $3.55 — litigation pile-on and halved analyst PTs keep pressure on

Eos shed $0.34 (-8.7%) Thu to close at $3.55, a fresh multi-week low, on no new catalyst. The move reflects persistent selling after the Q2 EPS blowout ($1.20 loss vs $0.19 est.), TD Cowen and Roth both cutting PTs to $4, and widening securities class-action scrutiny.

$3.55 -8.69% · close · Thu Aug 20 2026 · Stooq/search delayed

Price (Thu Aug 20): Closed $3.55 (-8.7%), range $3.53–$3.77; prior close ~$3.89. Tape: slow grind from pre-mkt ~$3.77 to lows $3.53, weak bounces sold. Partial session volume ~2.4M vs 22.1M avg.
Analyst resets (post-Q2): TD Cowen cut PT $8→$4 (Hold); Roth Capital $6→$4 (Neutral). Both targets now at or below today’s close — signaling limited sell-side conviction and acting as a ~$4 sentiment ceiling.
Legal overhang: Multiple law firms (incl. Bronstein, Gewirtz) probing EOSE for misrepresentations on production, ops, and guidance. Class action (filed Apr 2026) covers buyers pre-Nov 5, 2025.
Q2 context: Q2 EPS -$1.20/share vs -$0.19 consensus; revenue $68.8M (+351% YoY) beat lightly, but ~$276M net loss and -500%+ profit margin weigh. FY guide tightened $300–$350M. No new EDGAR filings or IR releases today.
Bull/Bear: Bull — $305M cash, $807M record backlog, FPUSA $263M funded Aug 04, Golden Dome & CAPAC contracts intact. Bear — deep EPS burn, class action risk, heavy dilution (364M+ shares), stock at recent lows.
Setup Fri Aug 21: No scheduled catalysts. Watch Form 4 insiders post-10-Q; Ofgem Window 1 final awards (~Sep 22 est.); NYSERDA BESS (~Sep 30 est.); Q3 earnings ~Nov 04 est. Support $3.42–$3.53; resistance ~$4.00.

2026-08-19 22:30:00 (Stockholm) · Post-close run · US session wrap

Q2 10-Q filed to EDGAR; Aug 19 close unconfirmed — overnight ATS ~$4.16

EOSE’s Q2 2026 10-Q landed on EDGAR (period Jun 30, 2026): 364M shares outstanding as of Aug 03 vs 340.6M at quarter-end, cash $305M. Aug 19 session close unavailable (sources delayed); overnight Blue Ocean ATS ~$4.16. No other new filings or catalysts today.

close unavailable · Aug 19 2026 · sources delayed · overnight ATS ~$4.16

Price (Wed Aug 19): Close unavailable — Yahoo data delayed (last confirmed session Aug 13 @ $4.16). Overnight Blue Ocean ATS: ~$4.16. Prior close: ~$4.02 (Aug 18). No catalyst-driven intraday move detected.
Q2 10-Q filed to EDGAR: Period ended Jun 30, 2026. Cash $305M (+$44M restricted). LT debt $454M (DOE) + $163M related-party notes. Shares 340.6M (Jun 30) → 364.2M (Aug 03) — 23.6M new shares issued post-quarter.
Balance sheet (10-Q): Series B preferred $713M (down from $1.36B at Dec 31). Warrants liability $389M ($135M public + $254M related party). Total liabilities $1.22B vs $1.76B Dec 31 — notable deleveraging.
Q2 recap: Revenue $68.8M (+351% YoY), backlog $807M (record, +25% seq.), FY guide $300–$350M. GM −71% (+132pp YoY). Line 2 Thorn Hill commissioning; full capacity target Q4 2026.
FPUSA / defense: $263M equity closed Aug 04; Blanquilla 800 MWh $100M PO active; 16 GWh development pipeline. Golden Dome / Dept of War contract intact. CAPAC MSA: 750 MWh DACH exclusivity to 2031.
Setup into Thu Aug 20: Watch Form 4 insider activity post-10-Q, Ofgem Window 1 final awards (~Sep 22 est.), NYSERDA BESS awards (~Sep 30 est.), Q3 earnings Nov 04 est. Support: ~$3.65; resistance: ~$4.35+.

2026-08-18 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE dips to ~$4.02 (-3.4%) as post-Q2 guidance re-rating grinds on

EOSE continued its post-earnings drift Tuesday (Aug 18) with no fresh catalysts or filings. Stock ~-17% from Aug 05 Q2 reaction high as market digests narrowed FY guide ($300–$350M); bull thesis rests on FPUSA optionality and analyst avg PT ~$7.

$4.02 -3.40% · close · Tue Aug 18 2026 · web search data delayed

Price action (Tue Aug 18): Closed ~$4.02 (-3.4% approx.) on quiet volume. No AH move. Intraday dip to ~$3.65 reversed into close — late-session buyers absorbed the early selloff. Source: web data, delayed.
No EDGAR filings (Aug 18): Nothing filed today. Q2 10-Q (Jun 30 quarter) still pending — now ~49 days post-quarter-end; likely imminent. Last filed: Aug 05 8-K (Q2 results) and Aug 06 Cerberus 13D/A (32.6% stake, 20M warrants at $5.481).
Q2 fundamentals (Aug 05): Revenue $68.8M (+351% YoY), backlog $807M (+25% seq.), FY guide tightened to $300–$350M (from $300–$400M). GM −71% (+132pp YoY). Cash $364M. Line 2 Thorn Hill 10% faster; full capacity target Q4 2026.
FPUSA / defense: $263M equity closed Aug 04; $100M Blanquilla 800 MWh PO received post-Q; 16 GWh development pipeline (~5 GWh active). Golden Dome for America contract (Dept of War, Jul 15) intact. CAPAC MSA: 750 MWh DACH exclusivity to 2031.
Sell-side (post-Q2): TD Cowen Hold $4 (from $8, Aug 06), B. Riley Neutral $5 (from $8), Stifel Buy $9 (from $10), JPM Neutral ~$6. Avg PT ~$7 (∼74% upside vs today’s close). Bear FV floor ~$3.20 (Simply Wall St.).
Setup into Wed Aug 19: No catalysts scheduled. Watch: Q2 10-Q filing (imminent), Ofgem Window 1 final awards (~Sep 22 est.), NYSERDA BESS awards (~Sep 30 est.), Q3 earnings Nov 04 est. Support: ~$3.65 (Tue intraday low); resistance: ~$4.16.

2026-08-14 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE slides to $4.16 on quiet Friday — $4.05 low pierces week’s $4.14 support

EOSE closed $4.16 (-1.89%) on below-average volume (63% of avg) with no news or filings. The $4.05 session low broke below the $4.14 floor that held Mon–Thu. No catalysts until Q2 10-Q drops and Ofgem final awards (~Sep 22).

$4.16 -1.89% · close · Fri Aug 14 2026 · Yahoo Finance delayed

Price action (Fri Aug 14): Closed $4.16 (-1.89%) range $4.05–$4.32, vol 16.3M (63% of avg 25.65M). Session low $4.05 pierced the $4.14 support floor that held Mon–Thu — quiet end-of-week drift with no identifiable catalyst.
No EDGAR filings (Aug 14): Nothing filed today. Q2 10-Q (Jun 30 quarter) pending. Most recent: Aug 05 8-K (Q2 results, revenue $68.8M) and Aug 06 Cerberus 13D/A (32.6% stake, 20M warrants at $5.481).
Q2 / manufacturing: Record $68.8M revenue (+351% YoY), backlog $807M, FY guide $300–$350M. GM −71%; Line 2 at Thorn Hill 10% faster than Line 1; consolidation to single site under evaluation. Golden Dome for America defense contract (Jul 15) intact.
FPUSA / TURBINE-X: $263M JV equity closed Aug 04. Blanquilla 800 MWh (PO received), Wildfire 400 MWh (selected), Stella 920 MWh (4-project pipeline). TURBINE-X JDA targets 2 GWh HPC-adjacent. No new FPUSA PR this week.
Sell-side: No new rating actions this week. Consensus avg PT ~$7.00 (~68% upside) vs $4.16 stock. TD Cowen Hold $4, Roth Neutral $4, JPM Neutral $6, Stifel Buy $9 (all post-Q2 Aug 05). Bear FV floor ~$3.20 (Simply Wall St.).
Setup into Mon Aug 17: No catalysts scheduled. Watch: Q2 10-Q filing (pending), Ofgem final Window 1 awards (~Sep 22 est.), NYSERDA BESS awards (~Sep 30 est.), Q3 earnings Nov 04 est. Support $4.05 (Fri low); resistance $4.32 (Fri high).

2026-08-13 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE flat ~$4.24 on quiet Thursday — no filings, week-long $4.14–$4.45 coil holds

EOSE drifted to ~$4.24 (~-0.1%) with no new catalysts or EDGAR filings, tracing a fourth straight session inside the $4.14–$4.45 range. Post-Q2 digest continues; low-energy setup into Friday with no known catalysts.

$4.24 -0.09% · est. close · Thu Aug 13 2026 · Yahoo Finance / search data delayed

Price action (Thu Aug 13): Closed ~$4.24 (~-0.1% vs Wed’s ~$4.22 est. close) on no identifiable catalyst. Stock has traded in the $4.14–$4.45 band all week — fourth consecutive session without a directional break. Volume near average.
No new EDGAR filings (Aug 13): Nothing filed today. Most recent activity: Q2 8-K (Aug 5, revenue $68.8M, backlog $807M) and Cerberus 13D/A (Aug 6, 32.6% stake, 20M warrants at $5.481 strike). Q2 10-Q (Jun 30 quarter) expected in coming weeks.
Q2 2026 recap (Aug 5): Record revenue $68.8M (+351% YoY), backlog $807M (+25% QoQ), FY2026 guidance tightened to $300–$350M. Net loss $275.7M; EPS -$1.20 vs consensus -$0.19 on Battery Line 2 ramp costs at Thorn Hill. H2 margin improvement is the key watch.
FPUSA / TURBINE-X: $263M JV capital close (Aug 4) backstops 1.8+ GWh pipeline — Blanquilla 800 MWh (PO received), Wildfire 400 MWh (selected), Stella 920 MWh (4 projects). TURBINE-X JDA targets 2 GWh in HPC-adjacent deployments.
Sell-side (post-Q2): TD Cowen Hold $4 (↓$8), Roth Neutral $4 (↓$6), JPMorgan Neutral $6 (↓$9), Stifel Buy $9 (↓$10). Consensus avg PT ~$7.00 (11 analysts) vs ~$4.24 stock — ~65% implied upside. CEO sold ~159k shares at $3.61 (Jul 27 option exercise).
Setup into Fri Aug 14: No catalysts scheduled. Watch: FPUSA Texas 10 project conversions (Q3), DOE loan draw timing, Ofgem LDES Window 1 (~Sep 2026). Support $4.14 (week low); resistance $4.45 (week high). Next earnings est. Nov 4, 2026.

2026-08-12 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE gaps +4.7% at open, fades to ~flat $4.22 est. close — Q2 digest continues

EOSE gapped up to $4.44 on no identifiable catalyst then sold off all session, closing approximately flat near $4.22 on near-avg volume. No new EDGAR filings today; market still absorbing Q2 beat and guidance tighten from Aug 5.

$4.22 -0.47% · est. close · Wed Aug 12 2026 · StockAnalysis delayed (2:37 PM ET snapshot)

Price action (Wed Aug 12): Opened $4.44 (+4.7% gap vs $4.24 prev close), ranged $4.14–$4.45 intraday before fading to ~$4.22 est. close (~flat). Est. volume ~20–22M shares (near 22.1M avg). No single catalyst; gap likely momentum/algorithmic follow-through post-Q2.
No new EDGAR filings (Aug 12): Nothing filed today. Most recent activity: Q2 8-K (Aug 5, revenue $68.8M, backlog $807M) and Cerberus 13D/A (Aug 6, 32.6% stake, 20M warrants at $5.481 strike). No Form 4 or 8-K today.
Q2 2026 recap (Aug 5): Record revenue $68.8M (+351% YoY), backlog $807M (+25% QoQ), FY2026 guidance tightened to $300–$350M. Cash ~$364M. Gross margin -69% to -73% reflecting Battery Line 2 ramp at Thorn Hill; margin improvement targeted H2.
FPUSA pipeline at 1.8 GWh: $263M JV capital raise closed Aug 4. Projects closed/selected: Blanquilla 800 MWh (Phase 1 PO received), Wildfire 400 MWh (selected), Stella 920 MWh (4 projects, selected). Q3 watch: Texas 10 conversions.
Sell-side post-Q2 (Aug 5–6): Stifel Buy $9 (↓$10), TD Cowen Hold $4 (↓$8), Roth Neutral $4 (↓$6), JPMorgan Neutral $6 (↓$9). Consensus avg PT ~$7.00 (11 analysts) vs ~$4.22 stock — ~65% implied upside to mean.
Setup into Thu Aug 13: No catalysts scheduled. Watch: FPUSA Texas 10 conversions (Q3), DOE loan draw timing, Ofgem LDES Window 1 (~Sep 2026). Support $4.14 (today's low); resistance $4.45 (today's high). Next earnings est. Nov 4, 2026.

2026-08-11 22:20:00 (Stockholm) · Post-close run · US session wrap

EOSE rebounds +3.1% to $3.94 — below-avg volume, digesting post-Q2 gains

EOSE gained +3.1% to close $3.94 on 23.2M shares (82% of avg) as the market continued digesting last week's Q2 beat: revenue $68.8M (+351% YoY), backlog $807M, guidance tightened to $300–$350M. No new EDGAR filings today; FPUSA pipeline advancing with 1.8 GWh of selected/closed projects.

$3.94 +3.14% · close · Tue Aug 11 2026 · Yahoo Finance (4:00 PM ET)

Price action (Tue Aug 11): Opened $3.72, traded $3.61–$4.23, closed $3.94 (+$0.12, +3.14% vs Aug 10's $3.82) on 23.2M shares (82% of 28.2M avg). AH: $3.93 (-0.15%). Quiet session — no single catalyst, post-Q2 consolidation continues.
No new EDGAR filings (Aug 11): Nothing filed today; most recent is Q2 8-K (Aug 5). Simply Wall St published three EOSE valuation pieces today: "bargain on cash flow but fully priced on sales" — no new data, pure digest.
Q2 recap (Aug 5): Record revenue $68.8M (+351% YoY), backlog $807M (+25% QoQ), 2026 guidance tightened to $300–$350M. Manufacturing consolidation to Thorn Hill targets gross margin improvement in H2 2026; EPS loss narrowed.
FPUSA pipeline 1.8 GWh: $263M capital raise closed Aug 5; $100M PO for 800 MWh Blanquilla Phase 1; 400 MWh Wildfire BESS selected; Stella Energy 920 MWh (4 projects) selected. Remaining Texas 10 conversions expected Q3 2026.
Sell-side post-Q2 (Aug 5–6): Stifel Buy $9 (↓$10), TD Cowen Hold $4 (↓$8), Roth Neutral $4 (↓$6). Consensus avg ~$7.89 (11 analysts) vs $3.94 stock — implies ~100% upside to mean PT.
Setup into Wed Aug 12: No catalysts scheduled. Watch: Q3 FPUSA Texas 10 conversions, DOE loan draw, Ofgem LDES Window 1 (~Sep 2026). Support $3.61 (today's low) / $3.11 (52-wk low). Next earnings est. Nov 4, 2026.

2026-08-10 22:20:00 (Stockholm) · Post-close run · US session wrap

EOSE slides -2.6% to $4.05 on avg volume — quiet Monday, no new catalysts

EOSE drifted lower Monday, closing $4.05 (-2.6% vs Fri's confirmed $4.16) on 15.8M shares (≈ 15.9M avg). No new SEC filings, IR releases, or analyst actions today. Market continues to digest the post-Q2 sell-side PT reset; AH ticked up to $4.09 on thin flow. Setup into Tuesday is quiet.

$4.05 -2.64% · close · Mon Aug 10 2026 · Public.com/Xignite confirmed 4:30 PM ET

Price action (Mon Aug 10): Opened $4.14, traded $3.99–$4.18, settled $4.05 (-$0.11, -2.6% vs Fri $4.16) on 15.8M shares (≈ avg). AH: $4.09 (+0.99%, range $4.04–$4.09). No single driver — likely residual gravity from last week's analyst PT cuts.
No new SEC filings or IR news today: Nothing filed on EDGAR Aug 10; most recent is the Aug 5 Q2 8-K. Eos IR page confirms no release since Aug 5. No Form 4 insider activity identified.
Post-Q2 PT cuts (Aug 5–6): Stifel $9 Buy (↓ from $10), TD Cowen $4 Hold (↓ from $8), Roth $4 Neutral (↓ from $6). Needham $11 Buy / JPMorgan $6 Neutral / Truist $7 Buy unchanged. Street avg ~$7 across 11 analysts — stock at $4.05 implies ~73% upside to mean PT.
FPUSA Blanquilla + Golden Dome: $100M PO for Phase I of 800 MWh Blanquilla BESS (FPUSA) booked post-Q2; $263M equity raise closed Aug 5, 1.8 GWh in pipeline. Jul 15 Golden Dome defense contract adds DOD credibility — commercial terms not yet disclosed.
Setup into Tue Aug 11: No scheduled catalysts. Watches: DOE loan draw announcement, FPUSA Blanquilla construction timeline, Ofgem LDES Window 1 binding awards (~Sep 22 est.). Support: $3.99 (today's low) / $3.11 (52-wk low). Resistance: $4.16 (Fri close).

2026-08-07 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE touches new 52-wk low $3.36 intraday, closes ~+2.7% on well-below-avg volume

Three days post-Q2 earnings, EOSE dipped to a fresh 52-week low of $3.36 early in the session before rebounding to close approx. $3.57 (+2.7%) on only 18M shares (vs 26.6M avg). No new filings or IR releases today. The Ofgem LDES Window 1 consultation closed today — binding awards expected ~Sep 22.

$3.57 +2.88% · approx close · Fri Aug 7 2026 · Yahoo Finance delayed (3:27 PM EDT snapshot; final tick unconfirmed)

Price action: New 52-wk low $3.36 hit early; recovered to close ~$3.57 (+2.7% vs Thu's $3.47) on ~18M shares — 32% below the 26.6M avg. Day range $3.36–$3.64. Thin Friday tape; no single identifiable catalyst for the intraday reversal.
No new SEC filings or IR news today: No 8-K or Form 4 filed Aug 7. Most recent filing is the Aug 5 Q2 earnings 8-K. Sell-side PT landscape unchanged — Needham $11 Buy, Stifel $10 Buy, Truist $7 Buy, TD Cowen $4 Hold, Roth $4 Neutral.
Simply Wall St fair-value cut (Aug 7): SWS trimmed EOSE fair value from ~$9.63 to ~$7.89, citing lower rev-growth assumption (~78% vs ~94%) and dilution from the $150M rights offering. Not a broker rating, but echoes post-Q2 consensus reset.
Ofgem LDES consultation closed today: Aug 7 was the deadline for Ofgem Window 1 cap & floor "minded-to" consultation. Binding final awards for Frontier Power UK's Eos pipeline expected ~Sep 22 (est.). No Eos IR comment today.
Macro: US July payrolls unexpectedly fell 23K (manufacturing hiring weak), yet S&P +0.6% and Nasdaq +1.3% — risk-on bid provided the broader tailwind that helped EOSE recover off its session lows.
Setup into Mon Aug 10: No scheduled catalysts. Key watches: DOE loan draw announcement, FPUSA Thorn Hill ramp update, additional analyst PT revisions. $3.36 is the near-term floor; a weak Monday open retests it.

2026-08-06 22:15:00 (Stockholm) · Post-close run · US session wrap

EOSE bounces 3% to $3.94 as PT cuts land; TD Cowen and Roth slash targets to $4

EOSE reclaimed $3.94 (+3.1% vs Aug 5’s $3.82 post-earnings low) on near-average volume despite a wave of sell-side PT cuts. TD Cowen halved its target to $4 from $8; Roth Capital cut to $4 from $6; Stifel trimmed to $9 from $10. Truist reaffirmed Buy/$7. AH flat at $3.95.

$3.94 +3.14% · close · Thu Aug 6 2026 · bounce from $3.82 (Aug 5) · public.com / web sources (delayed)

Price action: Closed $3.94 (+$0.12, +3.1%) on 23.3M shares (vs 22.1M avg) — technical stabilisation from Aug 5’s $3.82 post-earnings close; day range $3.61–$4.23. AH $3.95 (+0.25%), no catalyst.
Sell-side PT cuts: TD Cowen lowered to $4 from $8; Roth Capital to $4 from $6; Stifel to $9 from $10 — all citing Q2 EPS miss (−$1.20 vs −$0.19 est) and FPUSA revenue concentration risk. Truist reaffirmed Buy/$7 (initiated Jul 13).
Q2 quality concerns: ~80% of Q2’s $68.8M revenue traced to a single FPUSA-related project; gross margin −71%; adj. EBITDA loss widened to −$71.4M. Record backlog $807M (+25% QoQ) and $375M FPUSA equity raised are the bull offsets.
FPUSA / capital floor: Rights offering closed Jul 23 raising >$250M (Cerberus + Hudson Bay), bringing total FPUSA equity to ~$375M above the original $263M target. DOE loan draw timing and Thorn Hill ramp pace are next.
Setup into Fri Aug 7: No catalysts scheduled; watch for additional analyst revisions, DOE loan draw news, and any FPUSA Blanquilla Phase I update. Consensus PT now stale — $4 floor cuts reset the near-term debate.

2026-08-05 22:20:00 (Stockholm) · Post-close run · US session wrap

Q2 sell-the-news: EOSE falls ~10% to $3.93 as guidance cut and revenue quality weigh

EOSE closed ~$3.93 (−9.7%) on Aug 5 as the Q2 call confirmed pre-open concerns: guidance tightened to $300–$350M and 80% of Q2 revenue was a single related-party project. Golden Dome DoD contract and CAPAC Energy DACH deal are genuine positives; −$191.8M H1 OCF burn and −71% gross margin are the key H2 overhangs.

$3.93 -9.66% · close · Wed Aug 5 2026 · sell-the-news vs $4.35 (Aug 4) · Quiver Quantitative / web sources (delayed)

Price action: EOSE closed ~$3.93, −9.7% vs Aug 4’s $4.35 close — textbook sell-the-news on elevated volume; the pre-earnings run-in had fully priced good news that only partially materialized.
Call framing: CEO Mastrangelo: “converting demand into profitable growth.” Market focused on the $50M guidance ceiling cut (now $300–$350M) and −71% gross margin; adj. EBITDA loss widened to −$71.4M vs −$51.6M YoY.
Golden Dome DoD: Eos Z3™ selected for a critical U.S. defense installation under the Golden Dome for America initiative (announced Jul 15, confirmed in Q2 release) — structured to scale; national security angle but no specific revenue figure disclosed.
Cash runway: $305.5M unrestricted at Jun 30; −$191.8M H1 OCF burn implies <2-quarter horizon at that rate; FPUSA $263M equity raised and DOE loan draw are the key bridge items management must quantify in H2.
Setup Thu Aug 6: Watch analyst PT revisions (consensus ~$7.89 avg, Buy, vs $3.93); key debate: Thorn Hill consolidation timeline, H2 revenue back-weighting vs the $300–$350M guide, and non-FPUSA backlog conversion.

2026-08-05 14:30:00 (Stockholm) · Pre-open run · overnight setup

Q2: revenue "record" but 80% related-party, FY guidance top end cut to $350M, FPUSA JV closes — the market’s "bad" read is mostly fair

The audited Q2 print is softer than the Jul 15 preliminary looked. Total revenue was $68.8M (+351% YoY) — but $55.0M of that (80%) came from a single Cerberus-financed related-party project that was contributed to FPUSA on Aug 4; third-party revenue was just $13.7M, DOWN 10% YoY. Eos cut the top of FY26 guidance to $300–$350M (from $300–$400M) and will consolidate manufacturing into Thorn Hill. Offsetting the gloom: the Frontier Power USA JV formally closed Aug 4 with ~$263M funded, and a $100M Blanquilla PO landed post-quarter. After a +16% run-up into the print, a negative premarket reaction is a reasonable "sell-the-news."

$4.35 +16.00% · prior close · Tue Aug 4 2026 (run-up into the print) · vs $3.75 Aug 3 · Finnhub; Aug 5 reaction developing

Revenue quality is the story: total revenue $68.8M (+351% YoY) but $55.0M (80%) was a single related-party project (Cerberus-financed, contributed to FPUSA on Aug 4). Strip it out and third-party revenue was $13.7M, down ~10% YoY ($15.2M in Q2’25). The headline growth is real cash but not broad commercial demand — this is the number behind the negative reaction.
Guidance cut: FY2026 revenue tightened to $300–$350M from $300–$400M — the floor held but the ceiling came down $50M, tied to the timing of consolidating production into the Thorn Hill facility. Management frames the consolidation as a lower-cost footprint; the market can also read it as capacity being rationalized.
Losses: optically huge, mostly non-cash. Net loss attributable was −$275.7M, but that is driven by mark-to-market swings on Cerberus warrants/derivatives tied to the quarter-end share price — not operations. The cleaner reads: GAAP operating loss −$83.8M (vs −$63.8M YoY), gross margin −71% (better than Q1’s −78% but still deep), and adjusted EBITDA loss −$71.4M (wider than −$51.6M YoY).
Cash burn accelerated: H1 operating cash outflow was −$191.8M (vs −$95.0M a year ago); total cash was $364.1M incl. restricted at Jun 30 ($305.5M unrestricted). That is before the ~$37.7M rights offering (settled Aug 3) and July financings, but the burn rate is the runway question the Aug 5 call must address.
The genuine positives: the Frontier Power USA JV formally closed Aug 4 (the long-open definitive agreement) with ~$263M raised and >$1B of deployable project capital; a $100M Blanquilla Phase I purchase order landed post-quarter; backlog is a record $807M (3.4 GWh); H1 revenue already exceeded all of FY2025; and Line 2 is running with a 10% cycle-time gain. Note ~49% of backlog is FPUSA/related-party.
Price into it: EOSE closed $4.35 (+16%) on Aug 4, a run-up into the print; the initial premarket reaction to the results is negative. Treat any intraday figure as developing until the close — the Aug 5 call (8:30am ET) and how management frames the guidance cut + Thorn Hill consolidation will set the tone.

2026-08-04 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE ~$4.38 pre-earnings hold; full audited Q2 lands pre-market Wed Aug 5

EOSE held Monday's +11% rights-offer pop, drifting to an estimated ~$4.38 close on Tue Aug 4 in a quiet, no-news session. The real event is tomorrow: full audited Q2 2026 (operating income, FCF, FPUSA definitive-agreement status) lands pre-market Wed Aug 5, replacing the Jul 15 preliminary.

$4.38 +16.80% · est close · Tue Aug 4 2026 · vs $3.75 Aug 3 · search-sourced (StockInvest.us) · verify at open

Close ~$4.38 (+~17% est): Search-sourced (StockInvest.us); no news or filings today — pure pre-earnings drift after Monday's +11% pop. Forecast was $3.52–$3.98; stock moved above range. Verify vs live at open Wed.
Full Q2 print pre-mkt Aug 5: Jul 15 prelim: $68–69M revenue, ~$807M backlog, ~$364M cash. Tomorrow adds audited operating income, real FCF, Line 2 throughput, and FY26 guidance update vs $300–$400M. Call 8:30am ET.
FPUSA definitive agreement: JV still lacks a signed definitive as of Aug 4. Watch the Aug 5 8-K and call — signed removes the thesis's biggest remaining risk; absent prolongs dilution uncertainty into Q3.
No new EDGAR filings Aug 4: No 8-K, Form 4, or supplement filed. EOSEW warrants (strike $5.481, 10-yr) have traded since the Aug 3 Nasdaq listing — warrant/common spread reflects market's FPUSA execution confidence.
Sell-side into the print: Truist Buy/$7, Stifel Buy/$10 (cut from $12), JPMorgan Neutral/$6, Needham Buy/$11. Consensus ~$7–$8 vs ~$4.38 est close — gap reflects dilution and margin-ramp risk, not demand.
Setup Aug 5: Audited Q2, FPUSA definitive-agreement, and FY26 guidance all land simultaneously pre-market. Call 8:30am ET. No FPUSA signing likely reverses the two-day rally even on a revenue beat.

2026-08-03 22:15:00 (Stockholm) · Post-close run · US session wrap

EOSE rips +11% to $3.75 into Wednesday’s Q2 print as EOSEW warrants list and the rights offering settles

EOSE jumped +10.9% to close $3.75 on Mon Aug 3 2026 — the day the rights offering settled and its new warrants began listing on Nasdaq as EOSEW. The move is best read as positioning two days ahead of the full audited Q2 results (pre-market Wed Aug 5), which replace the Jul 15 preliminary print and reveal real operating income, cash burn and — critically — whether the three-way Frontier Power USA definitive agreement has been signed.

$3.75 +10.95% · close · Mon Aug 3 2026 · vs $3.38 Jul 31 close · Finnhub delayed

Close $3.75 (+10.9%): EOSE opened $3.35 and ran to a $3.80 intraday high, closing $3.75 vs the $3.38 Jul 31 close (day range $3.22–$3.80). It is the sharpest up-day in weeks but still ~26% below the $5.06 Jul 6 high — a relief bounce into earnings, not a trend break. (Finnhub, delayed.)
EOSEW warrants now listed: Eos filed a Form 8-A12B and Nasdaq listing certification on Aug 3 to register the rights-offering warrants for trading as EOSEW. That clears the “listing not assured” caveat we flagged on Jul 23 — the ~3.02M warrants (strike $5.481, 10-yr) are now exchange-tradable rather than stranded.
Rights offering settled: the ~$37.7M raise (6,885,218 units, 25.2% take-up) reached its expected on-or-about Aug 3 settlement — 6,885,218 new shares (+2.0%) plus the EOSEW warrants distributed by Broadridge. NOTE: this raised $37.7M, not $150M; the rights were only ~14% of the ~$263M total raised for Frontier Power USA (rights + Hudson Bay + Cerberus).
The real event is Wednesday: full audited Q2 2026 lands pre-market Aug 5 (call 8:30am ET). The Jul 15 preliminary print gave record revenue ($68–$69M, >3× shipments YoY) and record backlog (~$807M, +25% QoQ) but no operating income or audited cash figure. Watch the Line 1+2 combined throughput, the cash bridge off the ~$364M prelim, and any FPUSA definitive-agreement update.
Sell-side, refreshed: Truist initiated Buy, $7 (Jul 2026) on manufacturing expansion and backlog; Stifel cut its target $12→$10 but kept Buy, flagging rights-offering dilution; JPMorgan sits at Neutral, $6 after its Jul cut. Even the low active target is above the $3.75 close — the debate is dilution and margin timing, not demand.
No new adverse filings: beyond the Aug 3 warrant-listing paperwork, EDGAR shows routine Form 4s (Jul 27–28) and an S-8; the Yung v. Eos securities class action remains early-stage with no ruling. Golden Dome (Jul 15) and the German/DACH CAPAC framework still anchor the demand-broadening story into the print.

2026-07-23 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE opened −2.3% on rights results; $263M FPUSA total clears the bar — Aug 5 Q2 call is next hard catalyst

EOSE opened at ~$3.89 (−2.3% from the $3.98 Jul 22 close) on the pre-market rights results (25.2% take-up, $37.7M of ~$150M raised). The headline miss obscures the broader picture: combined with Hudson Bay and Cerberus, total FPUSA financing is ~$263M, above the original target and sized to support >$1B of deployable project capital. Session close not confirmed from a primary source at time of writing. Rights settlement ~Aug 3; Q2 earnings call Aug 5 is the next hard event.

$3.89 -2.26% · intraday · shortly after open · Jul 23 2026 · Finnhub via pre-open note; Jul 23 session close not yet confirmed

Session open: EOSE printed ~$3.89 shortly after the Jul 23 open (−2.3% vs the $3.98 Jul 22 close) — initial market reaction to the sub-target rights take-up. Jul 23 official close not confirmed from a primary source at time of writing; MacroTrends last-published close remains the Jul 22 figure of $3.98. Volume and directional trend into the close unavailable.
Rights results (pre-market 8-K, Jul 23): 6,885,218 of 27,367,171 units subscribed — 25.2% take-up, ~$37.7M gross vs the ~$150M maximum. Subscribers paid $5.481 into a $3.98 close — 37.7% premium implies strategic pro-rata defence, not retail arbitrage. Combined with Hudson Bay + Cerberus: ~$263M gross raised for Frontier Power USA, exceeding the original target, set to support >$1B of deployable project capital.
Dilution now in motion: 6,885,218 new shares (+2.0% on the Q1 count) plus ~3,021,234 EOSEW warrants ($5.481 strike, 10-yr term) to distribute on or about Aug 3, 2026. Eos applied to list EOSEW on Nasdaq — no assurance of approval; warrants may be illiquid if denied. Watch post-settlement 13D/A + Form 4 filings to identify the 25% exercisers.
Sell-side: JPMorgan PT $6 (cut from $9, Jul 21, Neutral). 11-analyst consensus: Buy, avg PT $8.78 (StockAnalysis). At the $3.89 open, EOSE traded 35% below the JPM floor — overhang is dilution pace and FPUSA project-close velocity ahead of the Aug 5 call.
No new filings post-open: No Form 4s, no 8-Ks, no press releases observed after the pre-market 8-K. No AH headlines in the first ~30 min post-close. Next EDGAR watch: insider filings ~Aug 3 post-settlement and the 10-Q/8-K on Aug 5.
Catalysts into next week: Rights settlement ~Aug 3 (13D/A + Form 4 flow); Aug 5 Q2 call at 8:30am ET — prelim print: record Q2 rev $68–69M, record $807M backlog, H1 2026 already > full-year 2025. Key question: three-way FPUSA JV definitive agreement — signed or not? Line 1+2 combined throughput and cash runway will also be closely watched.

2026-07-23 15:35:00 (Stockholm) · Pre-open run · overnight setup

Rights offering raises $37.7M on 25% take-up — FPUSA total hits ~$263M, above target

Eos disclosed the rights-offering results pre-open today: 6,885,218 of 27,367,171 units subscribed — a 25.2% take-up raising ~$37.7M gross against the ~$150M maximum, with 20.5M units lapsing worthless. Subscribers paid $5.481 while the stock closed $3.98 on Jul 22, a ~38% premium, so this looks like pro-rata defence rather than opportunistic buying. Combined with Hudson Bay and Cerberus, Eos says ~$263M gross is now raised for Frontier Power USA — above its own target. Next: settlement on/about Aug 3, then the Aug 5 Q2 call.

$3.89 -2.26% · intraday · Thu Jul 23 2026, shortly after the open · vs $3.98 Jul 22 close · Finnhub

The number: 6,885,218 units subscribed of 27,367,171 distributed — 25.2% take-up, ~$37.7M gross vs the ~$150.0M maximum. The remaining 20,481,953 units expired unexercised at 5pm ET Jul 21 and are worthless. Tabulated by Broadridge; disclosed in today’s 8-K (Item 8.01, Exhibit 99.1).
Correction to our Jul 21 note: we wrote that the targeted $150M “goes unraised.” That was wrong — about a quarter of it was raised. The shortfall against the maximum is ~$112.3M, not the full $150M.
Why exercise into a ~38% loss? Paying $5.481 with EOSE at $3.98 is irrational at spot, and the attached 0.4388 warrant struck at the same $5.481 carries little value. A 25% take-up therefore points at holders defending pro-rata ownership rather than retail chasing a discount — the offering also extended to 2023/2025 warrant holders. Watch post-settlement 13D/A and Form 4 filings for who actually stepped up.
Dilution: 6,885,218 new shares (+2.0% on the Q1 339.5M count) plus ~3,021,234 warrants at a $5.481 strike — ~2.9% fully diluted. Shares, warrants and sale proceeds distribute on or about Aug 3, 2026. Eos notes completion “remains subject to the satisfaction of certain conditions,” so this is not yet closed.
FPUSA funding cleared its bar: rights + the Hudson Bay investment + the Cerberus commitment total ~$263M gross — which Eos says exceeds the target set when the JV was announced and should initially support more than $1B of deployable project capital. The rights supplied only ~14% of that total, which is why a 75% miss on the rights is not a 75% miss on the JV.
Watch the warrant listing: Eos has applied to trade the new warrants on Nasdaq as EOSEW, but explicitly warns the application may not be approved — in which case they may not trade at all. Next hard catalyst is the Aug 5 Q2 call, where the three-way FPUSA definitive agreement is the item to press on.
Price: EOSE closed $3.98 on Wed Jul 22 (−6.1%), the last completed session. In early trade on Jul 23 it is around $3.89 (≈2.3%) — an intraday print minutes after the open, not a close. The market’s first read on the results is therefore mildly negative, but the session is young.

2026-07-23 15:25:00 (Stockholm) · Pre-open run · overnight setup

Rights offering raises $37.7M on 25% take-up — not the zero the lapsed-OTM read implied; FPUSA funding hits ~$263M

Eos disclosed the rights-offering results pre-open today: 6,885,218 of 27,367,171 units were subscribed — a 25.2% take-up raising ~$37.7M gross against the ~$150M maximum, with 20.5M units lapsing worthless. Subscribers paid $5.481 while the stock closed $3.98 on Jul 22, a 37.7% premium — so this was strategic, not opportunistic, money. Combined with Hudson Bay and Cerberus, Eos says ~$263M gross is now committed to Frontier Power USA, above its own target.

$3.98 -6.13% · close · Wed Jul 22 2026 · last completed session; results published pre-open Jul 23

The number: 6,885,218 units subscribed of 27,367,171 distributed — 25.2% take-up, ~$37.7M gross vs the ~$150.0M maximum. The remaining 20,481,953 units expired unexercised at 5pm ET Jul 21 and are worthless. Tabulated by Broadridge; disclosed in today's 8-K (Item 8.01).
Correction to our Jul 21 note: we wrote that the targeted $150M "goes unraised." That was wrong — roughly a quarter of it was raised. The shortfall against the maximum is ~$112.3M, not the full $150M.
Why exercise into a 38% loss? Paying $5.481 with EOSE at $3.98 is irrational at spot, and the attached 0.4388 warrant struck at the same $5.481 carries little value. A 25% take-up therefore points at holders defending pro-rata ownership rather than retail chasing a discount — the offering also extended to 2023/2025 warrant holders. Watch the post-settlement 13D/A and Form 4s for who actually stepped up.
Dilution: 6,885,218 new shares (+2.0% on the Q1 339.5M count) plus ~3,021,234 warrants at a $5.481 strike — ~2.9% fully diluted. Shares, warrants and sale proceeds distribute on or about Aug 3, 2026. Eos notes completion "remains subject to the satisfaction of certain conditions," so this is not yet closed.
FPUSA funding cleared its bar: rights + the Hudson Bay investment + the Cerberus commitment total ~$263M gross — which Eos says exceeds the target set when the JV was announced and should initially support more than $1B of deployable project capital. The rights offering supplied only ~14% of that total, which is why a 75% miss on the rights is not a 75% miss on the JV.
Watch the warrant listing: Eos has applied to trade the new warrants on Nasdaq as EOSEW, but explicitly warns the application may not be approved — in which case they may not trade at all. Next hard catalyst is the Aug 5 Q2 call, where the three-way JV definitive agreement is the item to press on.
Price action (last completed session): EOSE closed $3.98 on Wed Jul 22, −6.1% from the $4.24 Jul 21 close. Today's results landed before the Jul 23 open, so there is no confirmed price reaction yet at the time of writing.

2026-07-21 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE +4.4% to $4.24 as EOSER rights expire OTM; JPM cuts PT to $6, Aug 5 call in focus

EOSE bounced 4.4% to $4.24 (17.8M vol, 80% of avg) as EOSER rights lapsed OTM at the $5.481 strike — dilution overhang cleared, but the targeted $150M FPUSA equity contribution goes unraised. JPMorgan cut PT $9→$6 (Neutral) today. Aug 5 Q2 earnings call is the next major catalyst.

$4.24 +4.43% · close · Jul 21 2026 · StockAnalysis/CBOE delayed

Price action: EOSE closed $4.24 (+4.4%) on 17.8M shares (80% of 22.1M avg). Range $4.07–$4.27; AH $4.26 (+0.47%). Broad tape green: S&P +0.89%, Nasdaq +1.29%.
EOSER rights expired 5pm ET — EOSE at $4.24 was ~23% below the $5.481 strike; ~27.4M units lapsed OTM. Eos's targeted $150M FPUSA contribution unraised; only the Jun 30 Hudson Bay $75M direct is closed.
JPMorgan (Mark Strouse) cut PT $9→$6 today, keeps Neutral — second JPM cut in 2026. Reflects capital shortfall from lapsed rights offering and ongoing execution risk ahead of Aug 5 Q2 results.
No new 8-K or Form 4 filings Jul 21. Most recent: Jul 15 8-K (prelim Q2 record revenue + Golden Dome Z3 NDAA win). Say Q&A closes Aug 2 5pm ET; Q2 call Aug 5 8:30am ET.
FPUSA at 1.8 GWh selected/closed (90% of 2 GWh reservation); KKR Capital Markets engaged for construction finance. Three-way JV definitive agreement (Eos/Cerberus/Hudson Bay) still outstanding — key update Aug 5.

2026-07-20 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE falls 6% to $3.96 on light volume; EOSER expires tomorrow OTM, Say Q&A opens

EOSE shed ~6% to $3.96 on well-below-average volume (7.96M vs 30.5M avg) with no fresh catalyst. The $5.481 EOSER rights expire tomorrow Jul 21 at 5pm ET — stock ~38% below the strike, near-certain to lapse. Say Q&A opened today ahead of the Aug 5 Q2 call; FPUSA definitive JV agreement the key pending watch.

$3.96 -6.20% · close · Jul 20 2026 · Yahoo Finance delayed

Price action: EOSE closed $3.96 (−6.2% vs ~$4.22 Jul 17) on subdued 7.96M volume — ~26% of the 30.5M 30-day avg. No news catalyst; pre-expiry rights-overhang pressure likely.
EOSER expires tomorrow Jul 21 at 5pm ET — stock ~38% below the $5.481 strike, rights near-certain to lapse unexercised. No backstop; $150M Frontier USA contribution target falls well short.
No new SEC filings Jul 18–20. Jul 15 8-K also flagged a DoW Golden Dome Z3 prototype win (~91% domestic content, NDAA/FEOC compliant) — defense demand vector not yet in Street models.
Say Q&A opens today 9am ET (closes Aug 2 5pm ET) ahead of Aug 5 Q2 call (8:30am ET). Key asks: FPUSA definitive JV close, combined Lines 1+2 throughput, and cash bridge.
FPUSA holds at 1.8 GWh selected/closed (90% of 2 GWh reservation); KKR Capital Markets engaged for construction finance. Three-way JV (Eos/Cerberus/Hudson Bay) definitive agreement still pending.

2026-07-17 22:30:00 (Stockholm) · Post-close run · US session wrap

EOSE steadies at ~$4.22 (+1%) as EOSER rights enter final weekend before Jul 21 expiry

EOSE recovered marginally on quiet Friday trade, closing ~$4.22 (+1%) after three consecutive down sessions. No new filings, analyst actions, or FPUSA updates on Jul 17. EOSER rights trade at ~$0.04 — ~23% OTM — near-certain to lapse unexercised Mon Jul 21 at 5pm ET. Say Q&A opens Jul 20; full Q2 call Aug 5.

$4.22 +1.00% · close · Jul 17 2026 · Yahoo/delayed approx

Price action: EOSE closed ~$4.22 (+1.0% vs $4.18 Jul 16 close) on subdued volume with no fresh catalyst. Stock is 41% below the $7.17 direct-offering price (Jun 30) and 23% below the $5.481 rights subscription strike.
EOSER rights near-worthless: closed ~$0.04, massively OTM (~23% below $5.481 strike). Market prices near-zero chance of exercise. Rights lapse Jul 21 5pm ET — $150M target falls well short; no backstop arrangement disclosed.
No new SEC filings Jul 17. Most recent: Jul 15 8-K (prelim Q2 rev $68-69M, backlog $807M, Line 2 commercial). No Form 4 insider activity filed today.
FPUSA platform at 1.8 GWh selected/closed (90% of 2 GWh Eos reservation) after Jul 14 Wildfire 400 MWh pick. No new FPUSA update Jul 17. Definitive JV agreement with Hudson Bay still pending.
Next catalysts: Say Technologies Q&A opens Jul 20; EOSER expires Jul 21 at 5pm ET; full audited Q2 call Aug 5 at 8:30am ET — watch Line 2 throughput, cash bridge, FPUSA definitive agreement.

2026-07-15 23:55:00 (Stockholm) · Post-close run · US session wrap

Eos picked for "Golden Dome" defense shield — same day as a record prelim Q2 ($68–69M rev, $807M backlog)

Two notable items Jul 15. After the close (~5pm ET), Eos said the U.S. Department of War selected it under the "Golden Dome for America" missile-defense initiative to deploy a Z3 zinc-based storage prototype at a critical defense installation — a strategic new demand door (national security), leaning directly on Z3's ~91% domestic content, NDAA/FEOC compliance and non-flammable safety. It's a prototype selection (multi-million $, size undisclosed) — a validation and a foot in the door, not yet a large order. Earlier, a pre-market 8-K pre-announced a record prelim Q2 (revenue $68–69M, backlog $807M); the stock closed ~+5% at ~$4.51 on light volume. EOSER rights still expire Jul 21, deeply OTM.

$4.51 +5.20% · close · Jul 15 2026 · MarketBeat/Stooq delayed

Golden Dome for America (Jul 15, ~5pm ET): U.S. Department of War selected Eos to deliver a Z3 LDES prototype at a critical defense installation for the national missile-defense shield. ~91% domestic content, Section 842 NDAA + FEOC compliant, made in Pittsburgh. A strategically meaningful new (defense) demand vector — but a prototype/selection, not a disclosed-size order yet.
Prelim Q2 (8-K, pre-mkt Jul 15): record revenue $68–69M on >3× YoY shipments; GM loss −69% to −73% (from −78% Q1); backlog record $807M (+25% QoQ, orders exceeded shipments). Cash ~$364M; customer collections $78M exceeded quarterly revenue.
Close: ~$4.51 (+5.2% vs $4.29 prev close); opened $4.61 on the prelim 8-K, day range $3.80–$4.66. Volume light vs. 22.1M average — gap more relieved than chased.
Line 2 operational update: achieving higher yields and faster cycle times than Line 1 in early ramp. Bipolar automation 50% through Site Acceptance Testing; full commissioning targeted July 2026. Commissioning is the start of the ramp, not the finish.
Truist upgraded to Strong-Buy, $7 PT (Jul 14) ahead of the prelim — first Strong-Buy on Street. Avg consensus Hold, avg PT $9.17 (11 analysts). JPMorgan Neutral, $6 PT. CFO Kroeker sold 79,309 shares Jul 7 at $4.68 (10b5-1 plan, tax withholding).
CORRECTION: Full Q2 print + call now confirmed Aug 5 at 8:30am ET per the 8-K (prior expectation Jul 29). Say Technologies Q&A opens Jul 20.
Next: EOSER rights (strike $5.481) expire Jul 21 — 6 days, deeply OTM. Key binary before expiry. Full audited Q2 on Aug 5: watch combined-line throughput, cash bridge, and FPUSA definitive-agreement status.

2026-07-15 16:00:00 (Stockholm) · Post-close run · US session wrap

Preliminary Q2: revenue $68–69M (>3× shipments YoY), margin loss narrows to −69/−73%, ~$364M cash

Eos pre-announced strong preliminary Q2 results on Jul 15 (an 8-K, two weeks ahead of the scheduled Jul 29 print): revenue of $68–69M — a record and a >3× jump in shipments YoY — with the gross-margin loss narrowing to −69/−73% (from −78% in Q1) and total cash of ~$364M. Notably, the pre-announcement lands with the EOSER rights (strike $5.481) deep out-of-the-money and expiring Jul 21 — good operating news, dropped at a moment that could help lift a struggling raise. Full audited Q2 is still Jul 29.

$4.09 · Last verified close ~$4.09 (Jul 13) · prelim-Q2 news broke Jul 15 — the dashboard price feed is lagging; see the live ticker for the current print

Preliminary Q2 (unaudited, 8-K Jul 15): revenue $68–69M vs $57M in Q1 (+~20% QoQ) on a more than three-fold YoY jump in shipments — a new company record. Gross-margin loss of −69% to −73%, improving from −78% in Q1.
First quarter with BOTH lines commercial: Line 2 (live since late June) is posting yield and cycle times ahead of Line 1 — the strongest evidence yet that the manufacturing scale-up is working. Start-up costs still pressure near-term cost absorption.
Liquidity: total cash incl. restricted ~$364M at Jun 30 (from $472M at Q1) — ~$108M used in the quarter, before the Frontier funding (rights offering + Hudson Bay registered direct) lands in Q3.
Context — the rights offering is struggling: EOSER expires Jul 21 at a $5.481 strike, well out-of-the-money after the stock fell to the low-$4s in mid-July (a Stifel PT cut to $10 and a 52-week low). Pre-announcing a record quarter now reads, at least partly, as an attempt to get the stock — and the raise — moving. We flag the timing; you weigh it.
Also since July 1: rights offering commenced Jul 2 (trading as EOSER); the Hudson Bay registered direct priced/closed; FPUSA converted a 920 MWh Stella portfolio (Jul 7); and governance changes — Haiyan Song to the board and Marie Martin as CLO (Jul 9).
Next: EOSER expiry Jul 21; full, audited Q2 earnings Jul 29 (watch combined line throughput, the real cash bridge, and FPUSA definitive-agreement status). Ofgem UK Window 1 was a miss for Frontier (§08b).